SETBP1

There are 3 papers on SETBP1 in aging research: 3 observational studies in people.

Gene

3 papers study it1 finding

1 new paper in 30 daysSee all 3

“ASXL1 (18 vs. 22 months, P = 0.012), RUNX1 (17 vs. 22 months, P = 0.001), and SETBP1 (20 vs. 27 months, P = 0.032) mutations predicted inferior OS.”
Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significanceInternational journal of hematology2021doi:10.1007/s12185-021-03210-x
  • 1 lab in 1 country
  • Funders: Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul and 2 more
  • Humans3

Associations

1

Overall survival

downin humans1

1 study
  1. SETBP1 predicts overall survival in humans (20 vs. 27 months, P = 0.032).

    “ASXL1 (18 vs. 22 months, P = 0.012), RUNX1 (17 vs. 22 months, P = 0.001), and SETBP1 (20 vs. 27 months, P = 0.032) mutations predicted inferior OS.”

    HumansCMML

    Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance

    International journal of hematology

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 paper in 12 months